Sandoz Awarded $137M In Generic Hypertension Drug Fight
By Law360 Staff · September 13, 2024, 8:28 PM EDT
United Therapeutics Corp. owes Sandoz Inc. $137.2 million for conduct that breached an earlier settlement agreement between the parties and effectively blocked the sale of Sandoz's generic version of an injectable...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login